AstraZeneca Chief Soriot Slams Reports on His Departure as ‘Fake News’
- Soriot says he feels fit enough to stay another five years
- Pharma executive speaks at cancer conference in Madrid
This article is for subscribers only.
AstraZeneca Plc Chief Executive Officer Pascal Soriot said reports of his imminent departure are “fake news” and he feels fit enough to spend another five years at the UK drugmaker.
“I read these rumors and I can tell you - there’s nothing further from the truth. This is totally made up. Absolutely made up,” he told Bloomberg in an interview at the European Society for Medical Oncology in Madrid, where Astra is presenting key studies on lung and breast cancer drugs in development.